Hydrogiene Reintroduces Surface Shield, Formerly Known as Medigene.

Business Editors

SAN DIEGO--(BUSINESS WIRE)--Sept. 24, 2002

A Hydrogiene Corp. (PinkSheets:HICS) company spokesperson announced that Hydrogiene's Surface Shield(TM) project will be reactivated as soon as funding availability required for final phase testing is in place, enabling Hydrogiene to resume testing required to validate Surface Shield's(TM) formula with Formula 51 claims and effectiveness, then to receive the required EPA blessing prior to marketing.

Surface Shield(TM), formerly called Medigene, incorporates the 51st formula formulated by Polymer Research Corp.'s chemists. Medigene patent applications were filed in 2001 by Polymer Research Corp., then assigned to Charles Kallmann, the company's chairman and CEO. Kallmann has now assigned patent rights to Surface Shield to the company.

Surface Shield(TM) was formulated to kill a broad variety of microbiologicals identified as bacterium, germs, virus and fungi for extended periods of time far in excess time-wise of what disinfectants available today on the markets are now capable of. Disinfectants available today are effective for only a few days at best, while Surface Shield(TM) with Formula 51 is formulated to be effective for weeks and months.

Testing, prior to its suspension while the company was shut down had resulted in Surface Shield(TM) being categorized by the FDA as 501 exempt.

Amongst microbiologicals, Surface Shield(TM) with Formula 51 is formulated to be effective against, to name a few, the following: e-coli, staphylococcus epidermidis, enterococcus, klebsiella pneumoniae, proteus mirabilis, candida albicans, staphylococcus aureus, chiamydia, mycoplasm hominis, g. vaginalis and salmonella.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.